CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Blueberry derivative may lower hypertension risk


19 January 2011

MedWire News: Individuals who consume more than one serving of blueberries per week may have a 10% lower risk for hypertension than those who consume no weekly servings of the fruit, study results suggest.

The association between blueberry consumption and hypertension is most likely the result of the high content of the flavonoid anthocyanin in blueberries, say the authors.

They add: “Our findings are exciting and suggest that an achievable dietary intake of anthocyanins may contribute to the prevention of hypertension.”

In the American Journal of Clinical Nutrition, Eric Rimm (Harvard School of Public Health, Boston, Massachusetts, USA) and colleagues explain: “These data are important because anthocyanins are present in commonly consumed fruit, such as blueberries, cranberries, and strawberries, which can be readily incorporated into the diet.

“An average portion of blueberries, blackcurrants, or blood orange juice can contain very high amounts of anthocyanins (>500 mg).”

Using food-frequency questionnaires completed every 4 years over a 14-year follow-up period, Rimm and team assessed the flavonoid intake of 133,914 women and 23,043 men (mean age of 36 years).

Analysis of the questionnaire results revealed that although the majority of the cohort’s total flavonoid intake came from tea (flavan-3-ol), the consumption of blueberries and strawberries made the greatest contribution to total anthocyanin intake.

In all, 34,647 participants (83.8% female) developed hypertension during the follow-up period.

When Rimm et al arranged all participants in quintiles according to anthocyanin intake, participants in the highest quintile (mean 18.0 mg/day) had an 8% lower risk for hypertension than those in the lowest quintile (mean 6.7 mg/day; p<0.03). This risk reduction was amplified to 12% among those aged 60 years or younger, and lessened to 4% in those aged over 60 years (p<0.001, p=0.02, respectively for interaction).

Pooled analyses of the anthocyanin intake of participants aged 60 years or younger revealed a 10% hypertension risk reduction among those who consumed more than one serving of blueberries per week compared with no blueberry consumption weekly (p=0.02).

The consumption of more than one serving of strawberries per week also reduced hypertension risk compared with no weekly consumption of strawberries; however this reduction was nonsignificant and less than that seen with blueberry consumption, at 3%.

Rimm and team found no association between the consumption of other individual flavonoid subclasses and hypertension risk reduction; however, pooled analyses suggested that flavonoid compounds from subclasses with B-ring hydroxylation and methoxylation patterns (flavones and flavan-3-ol subclasses) were associated with reduced rates of hypertension in the cohort.

The researchers conclude that the study findings “warrant further investigation, including intervention studies to test optimal doses of anthocyanin-rich foods for the prevention of hypertension and to underpin guidelines for the prevention and treatment of hypertension.”

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2011

Am J Clin Nutr 2010; Advance online publication



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions